Welcome to LookChem.com Sign In|Join Free
  • or
(1R,2R)-2-(3,4-difluorophenyl)cyclopropanecarbonyl azide is a chiral compound characterized by its specific stereochemistry, with the R configuration at both the first and second carbon atoms. It features a cyclopropane ring fused to a carbonyl group, which is further substituted with an azide group and a 3,4-difluorophenyl moiety. This molecule is known for its reactivity and utility in the synthesis of various pharmaceutical compounds.

378236-67-0

Post Buying Request

378236-67-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

378236-67-0 Usage

Uses

Used in Pharmaceutical Industry:
(1R,2R)-2-(3,4-difluorophenyl)cyclopropanecarbonyl azide is used as a synthetic intermediate for the production of Ticagrelor (T437700), which is the first reversible oral P2Y12 receptor antagonist. Ticagrelor provides faster, greater, and more consistent ADP-receptor inhibition compared to Clopidogrel, making it a valuable alternative in the treatment of acute coronary syndromes (ACS). (1R,2R)-2-(3,4-difluorophenyl)cyclopropanecarbonyl azide's unique structure and reactivity enable the development of new therapeutic agents with improved efficacy and safety profiles.

Check Digit Verification of cas no

The CAS Registry Mumber 378236-67-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,7,8,2,3 and 6 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 378236-67:
(8*3)+(7*7)+(6*8)+(5*2)+(4*3)+(3*6)+(2*6)+(1*7)=180
180 % 10 = 0
So 378236-67-0 is a valid CAS Registry Number.

378236-67-0Relevant academic research and scientific papers

General Cyclopropane Assembly by Enantioselective Transfer of a Redox-Active Carbene to Aliphatic Olefins

Montesinos-Magraner, Marc,Costantini, Matteo,Ramírez-Contreras, Rodrigo,Muratore, Michael E.,Johansson, Magnus J.,Mendoza, Abraham

supporting information, p. 5930 - 5935 (2019/02/24)

Asymmetric cyclopropane synthesis currently requires bespoke strategies, methods, substrates, and reagents, even when targeting similar compounds. This approach slows down discovery and limits available chemical space. Introduced herein is a practical and versatile diazocompound and its performance in the first unified asymmetric synthesis of functionalized cyclopropanes. The redox-active leaving group in this reagent enhances the reactivity and selectivity of geminal carbene transfer. This effect allowed the asymmetric cyclopropanation of various olefins, including unfunctionalized aliphatic alkenes, that enables the three-step total synthesis of (?)-dictyopterene A. This unified synthetic approach delivers high enantioselectivities that are independent of the stereoelectronic properties of the functional groups transferred. Our results demonstrate that orthogonally differentiated diazocompounds are viable and advantageous equivalents of single-carbon chirons.

Synthesis of 2-(3,4-difluorophenyl)cyclopropanamine derivatives and salts

-

, (2013/10/21)

The present invention relates to the field of organic synthesis and describes the synthesis of specific intermediates suitable for the preparation of triazolopyrimidine compounds such as ticagrelor.

SYNTHESIS OF 2-(3,4-DIFLUOROPHENYL)CYCLOPROPANAMINE DERIVATIVES AND SALTS

-

Page/Page column 21, (2013/10/21)

The present invention relates to the field of organic synthesis and describes the synthesis of specific intermediates suitable for the preparation of triazolopyrimidine compounds such as ticagrelor.

From ATP to AZD6140: The discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosis

Springthorpe, Brian,Bailey, Andrew,Barton, Patrick,Birkinshaw, Timothy N.,Bonnert, Roger V.,Brown, Roger C.,Chapman, David,Dixon, John,Guile, Simon D.,Humphries, Robert G.,Hunt, Simon F.,Ince, Francis,Ingall, Anthony H.,Kirk, Ian P.,Leeson, Paul D.,Leff, Paul,Lewis, Richard J.,Martin, Barrie P.,McGinnity, Dermot F.,Mortimore, Michael P.,Paine, Stuart W.,Pairaudeau, Garry,Patel, Anil,Rigby, Aaron J.,Riley, Robert J.,Teobald, Barry J.,Tomlinson, Wendy,Webborn, Peter J.H.,Willis, Paul A.

, p. 6013 - 6018 (2008/04/02)

Starting from adenosine triphosphate (ATP), the identification of a novel series of P2Y12 receptor antagonists and exploitation of their SAR is described. Modifications of the acidic side chain and the purine core and investigation of hydrophobic substituents led to a series of neutral molecules. The leading compound, 17 (AZD6140), is currently in a large phase III clinical trial for the treatment of acute coronary syndromes and prevention of thromboembolic clinical sequelae.

Novel triazolo pyrimidine compounds

-

, (2008/06/13)

The present invention relates to a pyrimidine compound (I) useful as a pharmaceutical intermediate, to a process for preparing said pyrimidine compound, to intermediates used in said process, and to the use of said pyrimidine compound in the preparation of pharmaceuticals.

Process for the preparation of cyclopropyl carboxylic acid esters and derivatives

-

, (2008/06/13)

The invention relates to a novel process for the preparation of certain cyclopropyl carboxylic acid esters and other cyclopropyl carboxylic acid derivatives; a novel process for the preparation of dimethylsulfoxonium methylide and dimethylsulfonium methylide; to the use of certain cyclopropyl carboxylic acid esters in a process for the preparation of intermediates that can be used in the synthesis of pharmaceutically active entities; and to certain intermediates provided by these processes.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 378236-67-0